Visualization of breast cancer with the first generation photoacoustic mammoscope - photoacoustic mammography

niversiteit Twente0 sites73 target enrollmentStarted: TBDLast updated: May 6, 2024

Conditions

Trial Snapshot

No summary available.

•Photoacoustic part:
•1)Adult women, who come to the Centre for Mammacare with a lesion suspicious for malignancy that, after clinical investigation and anamnesis is classified as a BIRADS 3-5 (phase 1 and 2) or a BIRADS 1 or 2 (phase 3) lesion. In addition the lesion or suspect must have been deemed as being manifestable in a photoacoustic examination;
•2) Patients in good general health that allows them to undergo the examination in a prone position for a period of 45 minutes;
•3) Patients who are fully competent to give informed consent.;DPS part:
•1) all inclusion criteria for photoacoustic imaging;
•2) patient who gave informed consent for the photoacoustic imaging study;
•3) patient who will have a ultrasound-guided breast biopsy to investigate the lesion, which should be accessible with the VACORA biopsy system.

•Photoacoustic part:
•1) Patients whose physical condition is expected to be insufficient for mounting the examination bed and staying on this bed for 45 minutes without too much discomfort;
•2) Patients who had a breast biopsy in 3 months prior to this study;
•3) Patients with bloody discharge, ulcers or wounds on the breast;
•4) Patients with a history of surgery or radiation therapy on the breast;
•5) Patients who are currently undergoing chemotherapy.;DPS part
•1) all under 'photoacoustic part'
•2) patient who don't gave informed consent for the photoacoustic part
•3) patient who use anticoagulantia;
•4) patients from which the lesion is inaccessible with the VACORA biopsy needle.

Sponsor

niversiteit Twente